Daniel Drucker, University Professor of Medicine at University of Toronto — Verified Quotes & Interview Transcripts

Recent appearances

Daniel Drucker - Citation Laureate 2026 in Physiology or Medicine

September 16, 2026 · 📺 Clarivate

The science behind the new wave of gut-hormone medicines is reshaping how we treat diabetes, obesity, and even heart, kidney, and liver disease. Daniel Drucker has been named a Citation Laureate 2026 in Physiology or Medicine for identification and characterization of Glucagon-Like Peptide-1 (GLP-1) and studies of its biological activity, together with Jens Juul Holst and Svetlana Mojsov. Clinician-scientist Daniel Drucker explains how decades of careful research on hormones that signal fullness became one of the most important medical breakthroughs of our time. You'll discover: Why res…

Watch on YouTube ↗
Skinny, Inc. part 1: the Canadian connection to Ozempic

February 23, 2026 · 📺 The Globe and Mail

Dr. Daniel Drucker’s research helped pave the way for Ozempic, the blockbuster GLP-1 class drug. The endocrinologist has been researching the effects on Ozempic’s active ingredient semaglutide in the body for decades.Today he’ll show us around his lab and explain how a stout lizard kept in a freezer helped unlock the science behind a drug taken by more than a million Canadians. Then, health reporter Kelly Grant tells us about rising obesity rates in Canada, and we’ll hear from a doctor who prescribes GLP-1s— and a patient who takes them. This is part of a three-part series. The next episod…

Watch on YouTube ↗
Acceptance speech of Daniel J. Drucker, 17th Frontiers of Knowledge Award in Biology and Biomedicine

June 20, 2025 · 📺 Fundación BBVA

Acceptance speech by Daniel J. Drucker, recipient of the BBVA Foundation Frontiers of Knowledge Award 2024 in Biology and Biomedicine, jointly awarded with Joel Habener, Jens Juul Holst and Svetlana Mojsov for his advances in the study of GLP-1, a key hormone in the treatment of diabetes and obesity. Drucker explains how research on GLP-1 has advanced the understanding of the mechanisms regulating glucose and appetite and their clinical applications, highlighting its impact on the development of more effective and safer treatments, as well as on improving the management and prevention of meta…

Watch on YouTube ↗
[Season 2] Ep 3: Decoding GLP-1 | Prof. Daniel Drucker on Reshaping Modern Medicine

May 29, 2025 · 📺 VinFuture Prize

With a strong dedication to highlighting cutting-edge scientific advancements, the VinFuture Foundation presents the third episode of “Unveil the Future” podcast, season 2. This season delves into transformative technologies reshaping our world through six captivating conversations with the visionary individuals driving this innovation. In this episode, the VinFuture Foundation is delighted to welcome back a very special guest: Prof. Daniel Drucker from the University of Toronto and the Lunenfeld-Tanenbaum Research Institute, Canada - Laureate of the 2023 VinFuture Special Prize for Innovator…

Watch on YouTube ↗
Daniel J. Drucker: “GLP-1 therapies could also help with Parkinson’s, Alzheimer’s, and addictions”

January 13, 2025 · 📺 Fundación BBVA

Awarded with the 17th BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine, physician and researcher Daniel J. Drucker explains how his pioneering work in the 1980s first revealed that GLP-1 stimulates insulin secretion, laying the groundwork for innovative therapies to treat type 2 diabetes. He highlights that these medications not only promote weight loss and lower the risk of hypoglycemia but also protect the heart, blood vessels, and kidneys, reducing heart attacks, strokes, and mortality. His current research explores GLP-1’s potential in neurodegenerative disorders, ad…

Watch on YouTube ↗
Straight Talk with Daniel Drucker on GLP-1: Ground Truths Podcast with Eric Topol

April 02, 2024 · 📺 Eric Topol

For more Ground Truths, visit: https://erictopol.substack.com/

Watch on YouTube ↗
Daniel Drucker - Beyond Diabetes

December 01, 2023 · 📺 Toronto Medical Historical Club

Beyond Diabetes: GLP-1 is Changing Outcomes for People with Cardiometabolic Diseases, November 27, 2023.

Watch on YouTube ↗
Fighting Diabetes with Dr. Daniel Drucker

December 05, 2022 · 📺 Exploring By The Seat Of Your Pants

Join Gairdner Award recipient Dr. Daniel Drucker in this program as part of our ongoing series with the Gairdner Foundation as he highlights his research and work to help understand the science behind diabates and other disorders which has directly led to the creation of theraputics used by over 100 million people globally! This program is geared towards grades 7-12. This program is part of our series with the Gairdner Foundation - https://gairdner.org/ for more info

Watch on YouTube ↗
Day 1 - Video 4: GLUCAGON ACTION THE KNOWN UNKNOWNS by Daniel Drucker

November 28, 2022 · 📺 Nicolai J. Wewer Albrechtsen

Professor, Daniel Drucker, Lunenfeld-Tanenbaum Research Institute (CA)

Watch on YouTube ↗
Dr. Daniel Drucker Gairdner Science Week Laureate Lecture

November 02, 2021 · 📺 CanadaGairdnerAwards

Dr. Daniel Drucker, 2021 Canada Gairdner International Award winner delivered a laureate lecture at 2021 Gairdner Science Week

Watch on YouTube ↗
Dan Drucker & Michael Nauck take us on a journey through the development of GLP-1 receptor agonists

October 21, 2021 · 📺 European Association for the Study of Diabetes

... just glucagon in a single gene but we had these glucagon-like peptides which were termed glp1 and glp2 and that realization in ...

Watch on YouTube ↗
2019 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence, Professor Daniel Drucker

October 11, 2021 · 📺 Novo Nordisk Foundation

Three decades ago, only a small number of researchers talked about gut hormones. Today, many people view these hormones as building blocks for developing new therapies to confront the obesity and diabetes epidemics that are sweeping the world. Daniel J. Drucker has studied the molecular mechanisms and physiological functions of hormones for 35 years. His studies unravelling their biological actions have led to several discoveries and the development of life-changing therapies. For his outstanding contributions, he is receiving the 2019 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence…

Watch on YouTube ↗

Other executives at University of Toronto

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →

Recent appearances

Other executives at University of Toronto

Keep reading the full archive